AIMS Analyze the clinical applicability of glucose metabolism indexes and continuous glucose monitoring data on the qualitative diagnosis of insulinoma. METHODS Involve 22 patients with insulinoma (insulinoma group), 11 patients with hypoglycemia (hypoglycemia group) and 31 people with normal glucose tolerance (control group). HbA1c, fasting blood glucose (FBG), insulin (FINS) and C-peptide (...

OBJECTIVE To characterize glucose levels during daily living using continuous glucose monitors (CGMs) in nondiabetic individuals. RESEARCH DESIGN AND METHODS Seventy-four healthy children, adolescents, and adults aged 9-65 years with normal glucose tolerance used a blinded CGM device for 3 to 7 days. RESULTS Sensor glucose concentrations were 71-120 mg/dl for 91% of the day. Sensor values w...

An artificial neural network (ANN) model for the prediction of glucose concentration in a glucose-insulin regulation system for type 1 diabetes mellitus is developed and validated by using the Continuous Glucose Monitoring System (CGMS) data. This network consists of structured framework according to the compartmental structure of the Hovorka-Wilinska model (HWM), and an additional update schem...

Type 2 diabetes is a chronic disease and maintaining a tight glycemic control is essential to prevent both microvascular and macrovascular complications, as demonstrated in previous studies. It is essential to monitor the glucose levels in order to achieve the targets. The blood glucose monitoring can be done by different methods: glycated haemoglobin A1c, self-monitoring of blood glucose (befo...

Continuous glucose monitoring (CGM) is a new technology that allows patients to measure glucose levels continuously over several days. It has several advantages over traditional glucose meters in that it does not involve repeated finger sticks and can measure trends and track changes in glucose levels over time. The Clinical and Laboratory Standards Institute, working with the Diabetes Technolo...